nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC29A1—Fluorouracil—colon cancer	0.284	0.366	CbGbCtD
Zalcitabine—SLC22A7—Fluorouracil—colon cancer	0.107	0.137	CbGbCtD
Zalcitabine—SLC22A7—Methotrexate—colon cancer	0.0589	0.0758	CbGbCtD
Zalcitabine—CYP3A7—Irinotecan—colon cancer	0.0432	0.0556	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0432	0.0556	CbGbCtD
Zalcitabine—CYP3A7—Vincristine—colon cancer	0.0378	0.0486	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0378	0.0486	CbGbCtD
Zalcitabine—CYP2C9—Capecitabine—colon cancer	0.0352	0.0453	CbGbCtD
Zalcitabine—CYP3A5—Irinotecan—colon cancer	0.0324	0.0417	CbGbCtD
Zalcitabine—CYP3A5—Vincristine—colon cancer	0.0283	0.0364	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—colon cancer	0.0251	0.0322	CbGbCtD
Zalcitabine—CYP2C9—Fluorouracil—colon cancer	0.0209	0.0268	CbGbCtD
Zalcitabine—CYP3A4—Irinotecan—colon cancer	0.0126	0.0163	CbGbCtD
Zalcitabine—CYP3A4—Vincristine—colon cancer	0.011	0.0142	CbGbCtD
Zalcitabine—DCK—Topotecan—Irinotecan—colon cancer	0.00428	1	CbGdCrCtD
Zalcitabine—Gemcitabine—TYMS—colon cancer	0.00262	0.674	CrCbGaD
Zalcitabine—CYP3A43—liver—colon cancer	0.00192	0.077	CbGeAlD
Zalcitabine—SLC29A2—vagina—colon cancer	0.00147	0.0588	CbGeAlD
Zalcitabine—SLC22A7—renal system—colon cancer	0.0013	0.0522	CbGeAlD
Zalcitabine—DCK—embryo—colon cancer	0.00127	0.0508	CbGeAlD
Zalcitabine—SLC29A2—liver—colon cancer	0.00124	0.0496	CbGeAlD
Zalcitabine—SLC22A7—digestive system—colon cancer	0.00107	0.0428	CbGeAlD
Zalcitabine—SLC29A1—renal system—colon cancer	0.00101	0.0403	CbGeAlD
Zalcitabine—SLC29A2—lymph node—colon cancer	0.00095	0.0381	CbGeAlD
Zalcitabine—CYP3A7—liver—colon cancer	0.000863	0.0346	CbGeAlD
Zalcitabine—SLC29A1—lymphoid tissue—colon cancer	0.000835	0.0334	CbGeAlD
Zalcitabine—SLC29A1—digestive system—colon cancer	0.000824	0.033	CbGeAlD
Zalcitabine—DCK—lymphoid tissue—colon cancer	0.000797	0.0319	CbGeAlD
Zalcitabine—SLC22A7—liver—colon cancer	0.000796	0.0319	CbGeAlD
Zalcitabine—DCK—digestive system—colon cancer	0.000787	0.0316	CbGeAlD
Zalcitabine—SLC29A1—bone marrow—colon cancer	0.00076	0.0304	CbGeAlD
Zalcitabine—CYP3A7-CYP3A51P—liver—colon cancer	0.000734	0.0294	CbGeAlD
Zalcitabine—SLC29A1—vagina—colon cancer	0.000728	0.0292	CbGeAlD
Zalcitabine—DCK—bone marrow—colon cancer	0.000726	0.0291	CbGeAlD
Zalcitabine—DCK—vagina—colon cancer	0.000695	0.0279	CbGeAlD
Zalcitabine—Gemcitabine—ABCB1—colon cancer	0.000665	0.171	CrCbGaD
Zalcitabine—SLC29A1—liver—colon cancer	0.000614	0.0246	CbGeAlD
Zalcitabine—Lamivudine—ABCB1—colon cancer	0.000605	0.155	CrCbGaD
Zalcitabine—DCK—liver—colon cancer	0.000587	0.0235	CbGeAlD
Zalcitabine—CYP3A5—renal system—colon cancer	0.000497	0.0199	CbGeAlD
Zalcitabine—SLC29A1—lymph node—colon cancer	0.000471	0.0189	CbGeAlD
Zalcitabine—DCK—lymph node—colon cancer	0.00045	0.018	CbGeAlD
Zalcitabine—CYP3A5—digestive system—colon cancer	0.000408	0.0163	CbGeAlD
Zalcitabine—CYP2C9—digestive system—colon cancer	0.000401	0.0161	CbGeAlD
Zalcitabine—CYP3A4—renal system—colon cancer	0.000373	0.0149	CbGeAlD
Zalcitabine—CYP2D6—renal system—colon cancer	0.000367	0.0147	CbGeAlD
Zalcitabine—CYP3A5—vagina—colon cancer	0.00036	0.0144	CbGeAlD
Zalcitabine—Ataxia—Capecitabine—colon cancer	0.000325	0.00172	CcSEcCtD
Zalcitabine—Alopecia—Vincristine—colon cancer	0.000324	0.00171	CcSEcCtD
Zalcitabine—Blood creatinine increased—Capecitabine—colon cancer	0.000324	0.00171	CcSEcCtD
Zalcitabine—Chills—Irinotecan—colon cancer	0.00032	0.00169	CcSEcCtD
Zalcitabine—Bladder pain—Methotrexate—colon cancer	0.00032	0.00169	CcSEcCtD
Zalcitabine—Urine output increased—Methotrexate—colon cancer	0.00032	0.00169	CcSEcCtD
Zalcitabine—Arrhythmia—Irinotecan—colon cancer	0.000319	0.00169	CcSEcCtD
Zalcitabine—Dry skin—Capecitabine—colon cancer	0.000317	0.00167	CcSEcCtD
Zalcitabine—Alopecia—Irinotecan—colon cancer	0.000316	0.00167	CcSEcCtD
Zalcitabine—Abdominal pain upper—Capecitabine—colon cancer	0.000316	0.00167	CcSEcCtD
Zalcitabine—Hypokalaemia—Capecitabine—colon cancer	0.000314	0.00166	CcSEcCtD
Zalcitabine—Nasopharyngitis—Capecitabine—colon cancer	0.000309	0.00163	CcSEcCtD
Zalcitabine—Back pain—Vincristine—colon cancer	0.000309	0.00163	CcSEcCtD
Zalcitabine—Flatulence—Irinotecan—colon cancer	0.000306	0.00162	CcSEcCtD
Zalcitabine—CYP3A4—digestive system—colon cancer	0.000306	0.0123	CbGeAlD
Zalcitabine—Gastritis—Capecitabine—colon cancer	0.000306	0.00162	CcSEcCtD
Zalcitabine—Arrhythmia—Fluorouracil—colon cancer	0.000306	0.00161	CcSEcCtD
Zalcitabine—Muscular weakness—Capecitabine—colon cancer	0.000305	0.00161	CcSEcCtD
Zalcitabine—CYP3A5—liver—colon cancer	0.000304	0.0122	CbGeAlD
Zalcitabine—Alopecia—Fluorouracil—colon cancer	0.000302	0.0016	CcSEcCtD
Zalcitabine—Lymphadenopathy—Methotrexate—colon cancer	0.000301	0.00159	CcSEcCtD
Zalcitabine—CYP2D6—digestive system—colon cancer	0.000301	0.0121	CbGeAlD
Zalcitabine—Back pain—Irinotecan—colon cancer	0.000301	0.00159	CcSEcCtD
Zalcitabine—Abdominal distension—Capecitabine—colon cancer	0.000301	0.00159	CcSEcCtD
Zalcitabine—CYP2C9—liver—colon cancer	0.000299	0.012	CbGeAlD
Zalcitabine—Muscle spasms—Irinotecan—colon cancer	0.000299	0.00158	CcSEcCtD
Zalcitabine—Dysphagia—Capecitabine—colon cancer	0.000299	0.00158	CcSEcCtD
Zalcitabine—Diabetes mellitus—Methotrexate—colon cancer	0.000296	0.00156	CcSEcCtD
Zalcitabine—Anaemia—Vincristine—colon cancer	0.000295	0.00156	CcSEcCtD
Zalcitabine—Agitation—Vincristine—colon cancer	0.000293	0.00155	CcSEcCtD
Zalcitabine—Polyuria—Methotrexate—colon cancer	0.000293	0.00155	CcSEcCtD
Zalcitabine—Sweating increased—Capecitabine—colon cancer	0.000291	0.00154	CcSEcCtD
Zalcitabine—Ill-defined disorder—Irinotecan—colon cancer	0.000288	0.00152	CcSEcCtD
Zalcitabine—Anaemia—Irinotecan—colon cancer	0.000287	0.00152	CcSEcCtD
Zalcitabine—Vertigo—Vincristine—colon cancer	0.000287	0.00152	CcSEcCtD
Zalcitabine—Leukopenia—Vincristine—colon cancer	0.000286	0.00151	CcSEcCtD
Zalcitabine—Vision blurred—Fluorouracil—colon cancer	0.000281	0.00148	CcSEcCtD
Zalcitabine—Malaise—Irinotecan—colon cancer	0.00028	0.00148	CcSEcCtD
Zalcitabine—Vertigo—Irinotecan—colon cancer	0.000279	0.00148	CcSEcCtD
Zalcitabine—Dysuria—Capecitabine—colon cancer	0.000279	0.00148	CcSEcCtD
Zalcitabine—Neutropenia—Capecitabine—colon cancer	0.000279	0.00148	CcSEcCtD
Zalcitabine—Syncope—Irinotecan—colon cancer	0.000279	0.00147	CcSEcCtD
Zalcitabine—Renal failure acute—Methotrexate—colon cancer	0.000279	0.00147	CcSEcCtD
Zalcitabine—Leukopenia—Irinotecan—colon cancer	0.000278	0.00147	CcSEcCtD
Zalcitabine—Convulsion—Vincristine—colon cancer	0.000277	0.00146	CcSEcCtD
Zalcitabine—Hypertension—Vincristine—colon cancer	0.000276	0.00146	CcSEcCtD
Zalcitabine—Anaemia—Fluorouracil—colon cancer	0.000275	0.00145	CcSEcCtD
Zalcitabine—Loss of consciousness—Irinotecan—colon cancer	0.000273	0.00144	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Methotrexate—colon cancer	0.000273	0.00144	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Capecitabine—colon cancer	0.000273	0.00144	CcSEcCtD
Zalcitabine—Myalgia—Vincristine—colon cancer	0.000272	0.00144	CcSEcCtD
Zalcitabine—Cough—Irinotecan—colon cancer	0.000271	0.00143	CcSEcCtD
Zalcitabine—Weight decreased—Capecitabine—colon cancer	0.00027	0.00143	CcSEcCtD
Zalcitabine—Hyperglycaemia—Capecitabine—colon cancer	0.000269	0.00142	CcSEcCtD
Zalcitabine—Hypertension—Irinotecan—colon cancer	0.000268	0.00142	CcSEcCtD
Zalcitabine—Leukopenia—Fluorouracil—colon cancer	0.000266	0.00141	CcSEcCtD
Zalcitabine—Depression—Capecitabine—colon cancer	0.000265	0.0014	CcSEcCtD
Zalcitabine—Discomfort—Irinotecan—colon cancer	0.000261	0.00138	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Capecitabine—colon cancer	0.000261	0.00138	CcSEcCtD
Zalcitabine—Oedema—Vincristine—colon cancer	0.00026	0.00138	CcSEcCtD
Zalcitabine—Jaundice—Capecitabine—colon cancer	0.000259	0.00137	CcSEcCtD
Zalcitabine—Infection—Vincristine—colon cancer	0.000259	0.00137	CcSEcCtD
Zalcitabine—Convulsion—Fluorouracil—colon cancer	0.000258	0.00136	CcSEcCtD
Zalcitabine—Osteoarthritis—Methotrexate—colon cancer	0.000257	0.00136	CcSEcCtD
Zalcitabine—Confusional state—Irinotecan—colon cancer	0.000256	0.00135	CcSEcCtD
Zalcitabine—Thrombocytopenia—Vincristine—colon cancer	0.000255	0.00135	CcSEcCtD
Zalcitabine—Oedema—Irinotecan—colon cancer	0.000254	0.00134	CcSEcCtD
Zalcitabine—Myalgia—Fluorouracil—colon cancer	0.000253	0.00134	CcSEcCtD
Zalcitabine—Infection—Irinotecan—colon cancer	0.000252	0.00133	CcSEcCtD
Zalcitabine—Hyperhidrosis—Vincristine—colon cancer	0.000252	0.00133	CcSEcCtD
Zalcitabine—Epistaxis—Capecitabine—colon cancer	0.000251	0.00133	CcSEcCtD
Zalcitabine—Discomfort—Fluorouracil—colon cancer	0.00025	0.00132	CcSEcCtD
Zalcitabine—Shock—Irinotecan—colon cancer	0.00025	0.00132	CcSEcCtD
Zalcitabine—Thrombocytopenia—Irinotecan—colon cancer	0.000248	0.00131	CcSEcCtD
Zalcitabine—Anorexia—Vincristine—colon cancer	0.000248	0.00131	CcSEcCtD
Zalcitabine—Hyperhidrosis—Irinotecan—colon cancer	0.000245	0.0013	CcSEcCtD
Zalcitabine—Confusional state—Fluorouracil—colon cancer	0.000245	0.00129	CcSEcCtD
Zalcitabine—Mood swings—Methotrexate—colon cancer	0.000244	0.00129	CcSEcCtD
Zalcitabine—Oedema—Fluorouracil—colon cancer	0.000243	0.00128	CcSEcCtD
Zalcitabine—Anorexia—Irinotecan—colon cancer	0.000242	0.00128	CcSEcCtD
Zalcitabine—Ataxia—Methotrexate—colon cancer	0.000242	0.00128	CcSEcCtD
Zalcitabine—Infection—Fluorouracil—colon cancer	0.000241	0.00128	CcSEcCtD
Zalcitabine—Rhinitis—Capecitabine—colon cancer	0.00024	0.00127	CcSEcCtD
Zalcitabine—Hepatitis—Capecitabine—colon cancer	0.000239	0.00126	CcSEcCtD
Zalcitabine—Thrombocytopenia—Fluorouracil—colon cancer	0.000238	0.00126	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000237	0.00125	CcSEcCtD
Zalcitabine—Pharyngitis—Capecitabine—colon cancer	0.000237	0.00125	CcSEcCtD
Zalcitabine—Tachycardia—Fluorouracil—colon cancer	0.000237	0.00125	CcSEcCtD
Zalcitabine—Insomnia—Vincristine—colon cancer	0.000236	0.00124	CcSEcCtD
Zalcitabine—Anorexia—Fluorouracil—colon cancer	0.000232	0.00122	CcSEcCtD
Zalcitabine—Visual impairment—Capecitabine—colon cancer	0.00023	0.00122	CcSEcCtD
Zalcitabine—Insomnia—Irinotecan—colon cancer	0.000229	0.00121	CcSEcCtD
Zalcitabine—CYP3A4—liver—colon cancer	0.000228	0.00914	CbGeAlD
Zalcitabine—Decreased appetite—Vincristine—colon cancer	0.000226	0.0012	CcSEcCtD
Zalcitabine—Dyspnoea—Irinotecan—colon cancer	0.000226	0.0012	CcSEcCtD
Zalcitabine—Somnolence—Irinotecan—colon cancer	0.000226	0.00119	CcSEcCtD
Zalcitabine—Fatigue—Vincristine—colon cancer	0.000225	0.00119	CcSEcCtD
Zalcitabine—CYP2D6—liver—colon cancer	0.000224	0.00899	CbGeAlD
Zalcitabine—Eye disorder—Capecitabine—colon cancer	0.000223	0.00118	CcSEcCtD
Zalcitabine—Dyspepsia—Irinotecan—colon cancer	0.000223	0.00118	CcSEcCtD
Zalcitabine—Tinnitus—Capecitabine—colon cancer	0.000223	0.00118	CcSEcCtD
Zalcitabine—Pain—Vincristine—colon cancer	0.000223	0.00118	CcSEcCtD
Zalcitabine—Flushing—Capecitabine—colon cancer	0.000222	0.00117	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000221	0.00117	CcSEcCtD
Zalcitabine—Decreased appetite—Irinotecan—colon cancer	0.000221	0.00117	CcSEcCtD
Zalcitabine—Eosinophilia—Methotrexate—colon cancer	0.00022	0.00116	CcSEcCtD
Zalcitabine—Insomnia—Fluorouracil—colon cancer	0.00022	0.00116	CcSEcCtD
Zalcitabine—Fatigue—Irinotecan—colon cancer	0.000219	0.00116	CcSEcCtD
Zalcitabine—Pancreatitis—Methotrexate—colon cancer	0.000218	0.00115	CcSEcCtD
Zalcitabine—Pain—Irinotecan—colon cancer	0.000217	0.00115	CcSEcCtD
Zalcitabine—Dyspnoea—Fluorouracil—colon cancer	0.000217	0.00114	CcSEcCtD
Zalcitabine—Somnolence—Fluorouracil—colon cancer	0.000216	0.00114	CcSEcCtD
Zalcitabine—Chills—Capecitabine—colon cancer	0.000214	0.00113	CcSEcCtD
Zalcitabine—Dyspepsia—Fluorouracil—colon cancer	0.000214	0.00113	CcSEcCtD
Zalcitabine—Arrhythmia—Capecitabine—colon cancer	0.000213	0.00113	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Vincristine—colon cancer	0.000213	0.00113	CcSEcCtD
Zalcitabine—Decreased appetite—Fluorouracil—colon cancer	0.000211	0.00112	CcSEcCtD
Zalcitabine—Alopecia—Capecitabine—colon cancer	0.000211	0.00112	CcSEcCtD
Zalcitabine—Feeling abnormal—Irinotecan—colon cancer	0.000209	0.0011	CcSEcCtD
Zalcitabine—Dysuria—Methotrexate—colon cancer	0.000208	0.0011	CcSEcCtD
Zalcitabine—Neutropenia—Methotrexate—colon cancer	0.000208	0.0011	CcSEcCtD
Zalcitabine—Pain—Fluorouracil—colon cancer	0.000208	0.0011	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Irinotecan—colon cancer	0.000207	0.0011	CcSEcCtD
Zalcitabine—Abdominal pain—Vincristine—colon cancer	0.000206	0.00109	CcSEcCtD
Zalcitabine—Body temperature increased—Vincristine—colon cancer	0.000206	0.00109	CcSEcCtD
Zalcitabine—Flatulence—Capecitabine—colon cancer	0.000205	0.00108	CcSEcCtD
Zalcitabine—Dysgeusia—Capecitabine—colon cancer	0.000204	0.00108	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Methotrexate—colon cancer	0.000203	0.00107	CcSEcCtD
Zalcitabine—Back pain—Capecitabine—colon cancer	0.000201	0.00106	CcSEcCtD
Zalcitabine—Abdominal pain—Irinotecan—colon cancer	0.000201	0.00106	CcSEcCtD
Zalcitabine—Body temperature increased—Irinotecan—colon cancer	0.000201	0.00106	CcSEcCtD
Zalcitabine—Feeling abnormal—Fluorouracil—colon cancer	0.0002	0.00106	CcSEcCtD
Zalcitabine—Muscle spasms—Capecitabine—colon cancer	0.0002	0.00106	CcSEcCtD
Zalcitabine—Depression—Methotrexate—colon cancer	0.000198	0.00104	CcSEcCtD
Zalcitabine—Vision blurred—Capecitabine—colon cancer	0.000196	0.00104	CcSEcCtD
Zalcitabine—Tremor—Capecitabine—colon cancer	0.000195	0.00103	CcSEcCtD
Zalcitabine—Ill-defined disorder—Capecitabine—colon cancer	0.000193	0.00102	CcSEcCtD
Zalcitabine—Urticaria—Fluorouracil—colon cancer	0.000193	0.00102	CcSEcCtD
Zalcitabine—Anaemia—Capecitabine—colon cancer	0.000192	0.00102	CcSEcCtD
Zalcitabine—Body temperature increased—Fluorouracil—colon cancer	0.000192	0.00101	CcSEcCtD
Zalcitabine—Hypersensitivity—Vincristine—colon cancer	0.000192	0.00101	CcSEcCtD
Zalcitabine—Malaise—Capecitabine—colon cancer	0.000188	0.000991	CcSEcCtD
Zalcitabine—Epistaxis—Methotrexate—colon cancer	0.000187	0.000988	CcSEcCtD
Zalcitabine—Vertigo—Capecitabine—colon cancer	0.000187	0.000988	CcSEcCtD
Zalcitabine—Hypersensitivity—Irinotecan—colon cancer	0.000187	0.000988	CcSEcCtD
Zalcitabine—Asthenia—Vincristine—colon cancer	0.000187	0.000988	CcSEcCtD
Zalcitabine—Syncope—Capecitabine—colon cancer	0.000187	0.000986	CcSEcCtD
Zalcitabine—Leukopenia—Capecitabine—colon cancer	0.000186	0.000984	CcSEcCtD
Zalcitabine—Palpitations—Capecitabine—colon cancer	0.000184	0.000971	CcSEcCtD
Zalcitabine—Loss of consciousness—Capecitabine—colon cancer	0.000183	0.000966	CcSEcCtD
Zalcitabine—Asthenia—Irinotecan—colon cancer	0.000182	0.000962	CcSEcCtD
Zalcitabine—Cough—Capecitabine—colon cancer	0.000182	0.000959	CcSEcCtD
Zalcitabine—Hypertension—Capecitabine—colon cancer	0.00018	0.000949	CcSEcCtD
Zalcitabine—Hypersensitivity—Fluorouracil—colon cancer	0.000179	0.000946	CcSEcCtD
Zalcitabine—Diarrhoea—Vincristine—colon cancer	0.000178	0.000942	CcSEcCtD
Zalcitabine—Hepatitis—Methotrexate—colon cancer	0.000178	0.00094	CcSEcCtD
Zalcitabine—Arthralgia—Capecitabine—colon cancer	0.000177	0.000936	CcSEcCtD
Zalcitabine—Myalgia—Capecitabine—colon cancer	0.000177	0.000936	CcSEcCtD
Zalcitabine—Pharyngitis—Methotrexate—colon cancer	0.000177	0.000933	CcSEcCtD
Zalcitabine—Anxiety—Capecitabine—colon cancer	0.000176	0.000933	CcSEcCtD
Zalcitabine—Discomfort—Capecitabine—colon cancer	0.000175	0.000925	CcSEcCtD
Zalcitabine—Diarrhoea—Irinotecan—colon cancer	0.000174	0.000917	CcSEcCtD
Zalcitabine—Dry mouth—Capecitabine—colon cancer	0.000173	0.000915	CcSEcCtD
Zalcitabine—Dizziness—Vincristine—colon cancer	0.000172	0.00091	CcSEcCtD
Zalcitabine—Pruritus—Fluorouracil—colon cancer	0.000172	0.000908	CcSEcCtD
Zalcitabine—Visual impairment—Methotrexate—colon cancer	0.000171	0.000906	CcSEcCtD
Zalcitabine—Confusional state—Capecitabine—colon cancer	0.000171	0.000905	CcSEcCtD
Zalcitabine—Oedema—Capecitabine—colon cancer	0.00017	0.000897	CcSEcCtD
Zalcitabine—Infection—Capecitabine—colon cancer	0.000169	0.000891	CcSEcCtD
Zalcitabine—Dizziness—Irinotecan—colon cancer	0.000168	0.000886	CcSEcCtD
Zalcitabine—Shock—Capecitabine—colon cancer	0.000167	0.000883	CcSEcCtD
Zalcitabine—Eye disorder—Methotrexate—colon cancer	0.000166	0.000878	CcSEcCtD
Zalcitabine—Diarrhoea—Fluorouracil—colon cancer	0.000166	0.000878	CcSEcCtD
Zalcitabine—Thrombocytopenia—Capecitabine—colon cancer	0.000166	0.000878	CcSEcCtD
Zalcitabine—Tinnitus—Methotrexate—colon cancer	0.000166	0.000876	CcSEcCtD
Zalcitabine—Tachycardia—Capecitabine—colon cancer	0.000166	0.000876	CcSEcCtD
Zalcitabine—Vomiting—Vincristine—colon cancer	0.000166	0.000875	CcSEcCtD
Zalcitabine—Skin disorder—Capecitabine—colon cancer	0.000165	0.000871	CcSEcCtD
Zalcitabine—Rash—Vincristine—colon cancer	0.000164	0.000868	CcSEcCtD
Zalcitabine—Hyperhidrosis—Capecitabine—colon cancer	0.000164	0.000867	CcSEcCtD
Zalcitabine—Dermatitis—Vincristine—colon cancer	0.000164	0.000867	CcSEcCtD
Zalcitabine—Headache—Vincristine—colon cancer	0.000163	0.000862	CcSEcCtD
Zalcitabine—Anorexia—Capecitabine—colon cancer	0.000162	0.000855	CcSEcCtD
Zalcitabine—Vomiting—Irinotecan—colon cancer	0.000161	0.000852	CcSEcCtD
Zalcitabine—Dizziness—Fluorouracil—colon cancer	0.000161	0.000849	CcSEcCtD
Zalcitabine—Rash—Irinotecan—colon cancer	0.00016	0.000845	CcSEcCtD
Zalcitabine—Dermatitis—Irinotecan—colon cancer	0.00016	0.000844	CcSEcCtD
Zalcitabine—Chills—Methotrexate—colon cancer	0.00016	0.000843	CcSEcCtD
Zalcitabine—Headache—Irinotecan—colon cancer	0.000159	0.00084	CcSEcCtD
Zalcitabine—Alopecia—Methotrexate—colon cancer	0.000157	0.000831	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000155	0.000817	CcSEcCtD
Zalcitabine—Vomiting—Fluorouracil—colon cancer	0.000154	0.000816	CcSEcCtD
Zalcitabine—Insomnia—Capecitabine—colon cancer	0.000154	0.000811	CcSEcCtD
Zalcitabine—Rash—Fluorouracil—colon cancer	0.000153	0.000809	CcSEcCtD
Zalcitabine—Dermatitis—Fluorouracil—colon cancer	0.000153	0.000809	CcSEcCtD
Zalcitabine—Headache—Fluorouracil—colon cancer	0.000152	0.000804	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—colon cancer	0.000152	0.000801	CcSEcCtD
Zalcitabine—Dyspnoea—Capecitabine—colon cancer	0.000151	0.0008	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—colon cancer	0.00015	0.000792	CcSEcCtD
Zalcitabine—Dyspepsia—Capecitabine—colon cancer	0.000149	0.00079	CcSEcCtD
Zalcitabine—Decreased appetite—Capecitabine—colon cancer	0.000148	0.00078	CcSEcCtD
Zalcitabine—Fatigue—Capecitabine—colon cancer	0.000146	0.000773	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—colon cancer	0.000146	0.000771	CcSEcCtD
Zalcitabine—Pain—Capecitabine—colon cancer	0.000145	0.000767	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—colon cancer	0.000144	0.000759	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—colon cancer	0.000143	0.000756	CcSEcCtD
Zalcitabine—Feeling abnormal—Capecitabine—colon cancer	0.00014	0.000739	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—colon cancer	0.00014	0.000738	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—colon cancer	0.000139	0.000735	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Capecitabine—colon cancer	0.000139	0.000734	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—colon cancer	0.000139	0.000732	CcSEcCtD
Zalcitabine—Cough—Methotrexate—colon cancer	0.000135	0.000714	CcSEcCtD
Zalcitabine—Urticaria—Capecitabine—colon cancer	0.000135	0.000713	CcSEcCtD
Zalcitabine—Abdominal pain—Capecitabine—colon cancer	0.000134	0.000709	CcSEcCtD
Zalcitabine—Body temperature increased—Capecitabine—colon cancer	0.000134	0.000709	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—colon cancer	0.000134	0.000709	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—colon cancer	0.000132	0.000697	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—colon cancer	0.000132	0.000697	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—colon cancer	0.00013	0.000688	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—colon cancer	0.000127	0.000673	CcSEcCtD
Zalcitabine—Infection—Methotrexate—colon cancer	0.000126	0.000663	CcSEcCtD
Zalcitabine—Hypersensitivity—Capecitabine—colon cancer	0.000125	0.000661	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—colon cancer	0.000124	0.000654	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—colon cancer	0.000123	0.000649	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—colon cancer	0.000122	0.000646	CcSEcCtD
Zalcitabine—Asthenia—Capecitabine—colon cancer	0.000122	0.000644	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—colon cancer	0.00012	0.000637	CcSEcCtD
Zalcitabine—Pruritus—Capecitabine—colon cancer	0.00012	0.000635	CcSEcCtD
Zalcitabine—Diarrhoea—Capecitabine—colon cancer	0.000116	0.000614	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000115	0.000608	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—colon cancer	0.000114	0.000604	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—colon cancer	0.000113	0.000595	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—colon cancer	0.000112	0.000594	CcSEcCtD
Zalcitabine—Dizziness—Capecitabine—colon cancer	0.000112	0.000593	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—colon cancer	0.000111	0.000588	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—colon cancer	0.00011	0.000581	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—colon cancer	0.000109	0.000576	CcSEcCtD
Zalcitabine—Pain—Methotrexate—colon cancer	0.000108	0.000571	CcSEcCtD
Zalcitabine—Vomiting—Capecitabine—colon cancer	0.000108	0.00057	CcSEcCtD
Zalcitabine—Rash—Capecitabine—colon cancer	0.000107	0.000566	CcSEcCtD
Zalcitabine—Dermatitis—Capecitabine—colon cancer	0.000107	0.000565	CcSEcCtD
Zalcitabine—Headache—Capecitabine—colon cancer	0.000106	0.000562	CcSEcCtD
Zalcitabine—Feeling abnormal—Methotrexate—colon cancer	0.000104	0.00055	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—colon cancer	0.000103	0.000546	CcSEcCtD
Zalcitabine—Urticaria—Methotrexate—colon cancer	0.0001	0.000531	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—colon cancer	9.99e-05	0.000528	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—colon cancer	9.99e-05	0.000528	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—colon cancer	9.31e-05	0.000492	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—colon cancer	9.07e-05	0.000479	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—colon cancer	8.94e-05	0.000472	CcSEcCtD
Zalcitabine—Diarrhoea—Methotrexate—colon cancer	8.65e-05	0.000457	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—colon cancer	8.36e-05	0.000442	CcSEcCtD
Zalcitabine—Vomiting—Methotrexate—colon cancer	8.04e-05	0.000425	CcSEcCtD
Zalcitabine—Rash—Methotrexate—colon cancer	7.97e-05	0.000421	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—colon cancer	7.96e-05	0.000421	CcSEcCtD
Zalcitabine—Headache—Methotrexate—colon cancer	7.92e-05	0.000418	CcSEcCtD
